Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms : prostate health outcomes in the Registry of Hypogonadism in Men. / Frans M. J. Debruyne, Hermann M. Behre, Claus G. Roehrborn, Mario Maggi, Frederick C. W. Wu, Fritz H. Schröder, Thomas Hugh Jones, Hartmut Porst, Geoffrey Hackett, Olivia A. Wheaton, Antonio Martin-Morales, Eric Meuleman, Glenn R. Cunningham, Hozefa A. Divan, Raymond C. Rosen

#PCSM; #ProstateCancer; benign prostatic hyperplasia; disease registry; hypogonadism; testosterone

Saved in:
Persons: DeBruyne, Frans M. J. [Author]; Behre, Hermann M. [Author]; Roehrborn, Claus G. [Author]; Maggi, Mario [Author]; Wu, Frederick C. W. [Author]; Schröder, Fritz H. [Author]; Jones, Thomas Hugh [Author]; Porst, Hartmut [Author]; Hackett, Geoffrey [Author]; Wheaton, Olivia A. [Author]; Martin-Morales, Antonio [Author]; Meuleman, Eric [Author]; Cunningham, Glenn R. [Author]; Divan, Hozefa A. [Author]; Rosen, Raymond C. [Author]
Format: eArticle
Language(s):English
Publication:February 2017
Part of:BJU international 119(2017), 2, Seite 216-224
ISSN:1464-410X
DOI:10.1111/bju.13578